Lauren R Teras, Carol E DeSantis, James R Cerhan, Lindsay M Morton, Ahmedin Jemal, Christopher R Flowers. CA Cancer J Clin 2016
Times Cited: 517
Times Cited: 517
Enrico Tiacci, Jae H Park, Luca De Carolis, Stephen S Chung, Alessandro Broccoli, Sasinya Scott, Francesco Zaja, Sean Devlin, Alessandro Pulsoni, Young R Chung, Michele Cimminiello, Eunhee Kim, Davide Rossi, Richard M Stone, Giovanna Motta, Alan Saven, Marzia Varettoni, Jessica K Altman, Antonella Anastasia, Michael R Grever, Achille Ambrosetti, Kanti R Rai, Vincenzo Fraticelli, Mario E Lacouture, Angelo M Carella, Ross L Levine, Pietro Leoni, Alessandro Rambaldi, Franca Falzetti, Stefano Ascani, Monia Capponi, Maria P Martelli, Christopher Y Park, Stefano A Pileri, Neal Rosen, Robin Foà, Michael F Berger, Pier L Zinzani, Omar Abdel-Wahab, Brunangelo Falini, Martin S Tallman. N Engl J Med 2015
Times Cited: 191
Times Cited: 191
List of shared articles
Times cited
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Xavier Troussard, Elsa Maître, Edouard Cornet. Am J Hematol 2022
Xavier Troussard, Elsa Maître, Edouard Cornet. Am J Hematol 2022
Advances in the Treatment of Hairy Cell Leukemia Variant.
Julie Tran, Charles Gaulin, Martin S Tallman. Curr Treat Options Oncol 2022
Julie Tran, Charles Gaulin, Martin S Tallman. Curr Treat Options Oncol 2022
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
Elsa Maitre, Edouard Cornet, Véronique Salaün, Pauline Kerneves, Stéphane Chèze, Yohan Repesse, Gandhi Damaj, Xavier Troussard. Cancers (Basel) 2022
Elsa Maitre, Edouard Cornet, Véronique Salaün, Pauline Kerneves, Stéphane Chèze, Yohan Repesse, Gandhi Damaj, Xavier Troussard. Cancers (Basel) 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
Jérôme Paillassa, Elsa Maitre, Xavier Troussard. Curr Oncol Rep 2022
Jérôme Paillassa, Elsa Maitre, Xavier Troussard. Curr Oncol Rep 2022
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
Jérôme Paillassa, Firas Safa, Xavier Troussard. Ther Adv Hematol 2022
Jérôme Paillassa, Firas Safa, Xavier Troussard. Ther Adv Hematol 2022
Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization.
Constantin A Dasanu, Juliana Alvarez-Argote, Catherine B Goff. Expert Opin Pharmacother 2022
Constantin A Dasanu, Juliana Alvarez-Argote, Catherine B Goff. Expert Opin Pharmacother 2022
Skin changes in hairy cell leukemia.
Ewa Robak, Dorota Jesionek-Kupnicka, Tadeusz Robak. Ann Hematol 2021
Ewa Robak, Dorota Jesionek-Kupnicka, Tadeusz Robak. Ann Hematol 2021